Department of Medical Physics, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.
Radiother Oncol. 2012 Aug;104(2):187-91. doi: 10.1016/j.radonc.2012.06.001. Epub 2012 Jul 26.
Radiation dose to the bulbomembranous urethra has been shown to correlate with urethral stricture formation. This retrospective case-control study was designed to explore the relationship between dose to the apical/peri-apical regions of the urethra and development of brachytherapy (BXT)-related urethral stricture.
Cases were patients who developed urethral stricture after treatment with BXT as monotherapy and who had urethral dosimetry post-implant. Each case was matched with a control that had not developed urethral stricture. Dosimetry was compared between cases and controls.
Twenty-three cases were pair matched with 23 controls. There were no significant differences between the two groups in terms of age, presenting Prostate Specific Antigen (PSA), International Prostate Symptom Score (IPSS) or Gleason score. The dose delivered to the peri-apical and apical urethra was significantly higher for cases when compared with controls (peri-apical urethra: mean V(150) 1.1 Vs 0.8 cc [p=0.02]; apical urethra: mean dose 200 Vs 174 Gy [p=0.01]). The distance from the prostate apex to isodose lines was also found to be significant in predicting stricture formation.
There was evidence to suggest that the development of BXT-related stricture was associated with radiation dose at the apical and peri-apical urethra. Attention to the dose delivered to those areas may minimise the risk of developing such morbidity.
已有研究表明,球海绵体肌尿道的照射剂量与尿道狭窄的形成有关。本回顾性病例对照研究旨在探讨尿道尖端/周围区域的剂量与近距离放射治疗(BXT)相关尿道狭窄的发展之间的关系。
病例为接受单纯 BXT 治疗后发生尿道狭窄且植入后有尿道剂量学的患者。每个病例均与未发生尿道狭窄的对照相匹配。比较病例和对照之间的剂量学数据。
23 例病例与 23 例对照配对。两组在年龄、前列腺特异性抗原(PSA)、国际前列腺症状评分(IPSS)或 Gleason 评分方面无显著差异。与对照组相比,病例组的尖端周围和尖端尿道的照射剂量明显更高(尖端周围尿道:平均 V(150)1.1 比 0.8 cc [p=0.02];尖端尿道:平均剂量 200 比 174 Gy [p=0.01])。从前列腺尖部到等剂量线的距离也被发现与狭窄形成有显著相关性。
有证据表明,BXT 相关狭窄的发生与尖端和尖端周围尿道的放射剂量有关。关注这些区域的剂量可能会降低发生这种发病率的风险。